Dr. Miso Gostimir, MD, MPH

Dr. Gostimir practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Gostimir's NPI, 1598487597, was assigned on September 15, 2022. Dr. Gostimir holds Pennsylvania license MD476883.

Dr. Gostimir's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Gostimir's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Gostimir is also affiliated with University Hospitals TriPoint Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Gostimir to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gostimir practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gostimir's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gostimir is licensed in Pennsylvania.

CMS data shows 82 Medicare services from Dr. Gostimir across 3 procedure codes in 2024, for 90 Medicare patients. Medicare paid $4,971 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Gostimir in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gostimir's median patient age at 71, with 62% women.

In 2024, Dr. Gostimir wrote 79 Medicare Part D claims for 43 patients. 76% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $476 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gostimir for performance year 2024, reported as part of a group. Dr. Gostimir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 47 general payments to Dr. Gostimir from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $671.